filmov
tv
Pfizer targets Omicron COVID variant with new vaccine trial
![preview_player](https://i.ytimg.com/vi/eaQM__Jdf-I/maxresdefault.jpg)
Показать описание
Pfizer and BioNTech are working on a trial to test a modified COVID-19 vaccine aimed at targeting the Omicron variant. Dr. William Schaffner, a professor of infectious diseases at Vanderbilt University Medical Center, joined CBS News to discuss the latest on the pandemic.
Pfizer targets Omicron COVID variant with new vaccine trial
Pfizer and Moderna update latest COVID vaccines to target the Omicron variant
Pfizer CEO: Three Covid shots against omicron variant equivalent to two targeting original strains
Pfizer: Booster dose of Covid vaccine neutralizes omicron variant
Moderna and Pfizer working on COVID-19 booster that targets omicron
Pfizer’s New Covid-19 Booster Targeting Omicron Could Be Authorized This Week
Pfizer Begins Study of Omicron Specific Covid Vaccine
Pfizer Testing Omicron-Specific Covid Vaccine
FDA authorizes Pfizer, Moderna booster shots targeting Omicron variant
Pfizer, BioNTech start testing Omicron vaccine
Pfizer’s vaccine that targets omicron comes out in March. This is why you shouldn’t wait for it
Pfizer says tweaked COVID-19 shots boost omicron protection
Pfizer says 3rd shot of COVID vaccine more effective at neutralizing Omicron variant
Pfizer, Moderna expect more details on omicron Covid variant within weeks
Moderna, Pfizer Begin Omicron Booster Roll Out
U.S. CDC approves Omicron-targeting boosters from Pfizer, Moderna
Pfizer vaccine could be quickly adapted for omicron variant
Biden Hails Pfizer Study That Shows Booster May Protect Against Omicron
FDA approves pair of vaccine booster shots designed to target omicron variant of COVID-19
Pfizer testing Omicron-based vaccine amid concerns about twin variant
Pfizer could have a new vaccine against omicron Covid variant in less than 100 days: CEO Bourla
FDA authorizes updated COVID booster shots to target Omicron
Pfizer develops Omicron-specific vaccine
New Omicron boosters available from Pfizer and Moderna with Sandra Fryhofer, MD
Комментарии